Ethical considerations for introducing RTS,S/AS01 in countries with moderate to high Plasmodium falciparum malaria transmission
Guardado en:
Autores principales: | Jeff D'Souza, David Nderitu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/eb855d8be8e049b8ba09b944b3115345 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Evaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission area.
por: Mark E Polhemus, et al.
Publicado: (2009) -
Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine.
por: Mohammad Zeeshan, et al.
Publicado: (2012) -
Assessment of genetic diversity of Plasmodium falciparum circumsporozoite protein in Sudan: the RTS,S leading malaria vaccine candidate
por: Nouh Saad Mohamed, et al.
Publicado: (2021) -
T cell responses to the RTS,S/AS01(E) and RTS,S/AS02(D) malaria candidate vaccines administered according to different schedules to Ghanaian children.
por: Daniel Ansong, et al.
Publicado: (2011) -
Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/AS01E malaria vaccine efficacy
por: Carlota Dobaño, et al.
Publicado: (2019)